Please provide your email address to receive an email when new articles are posted on . Women with higher BMI, greater anatomical failure and smoking had a greater recurrence of pelvic organ prolapse ...

Circulating tumor DNA, or ctDNA, can predict metastatic risk in patients who receive bladder-sparing treatment for ...

New research from Memorial Sloan Kettering Cancer Center (MSK) medical oncologist Dean Bajorin, MD, and colleagues found that patients who received nivolumab (Opdivo®) after bladder cancer surgery ...

Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...

Immunotherapy after surgery helped reduce cancer recurrence in patients with urothelial cancer of the bladder or other sites in the urinary tract that had invaded the muscle and therefore posed a high ...

DEAR MAYO CLINIC: I just had a total hysterectomy due to an abnormal Pap smear. At that time, my bladder was also corrected, since it had been descended for many years. What kind of care is most ...

“Incorporating ctDNA into the decision-making process helps refine who can safely keep their bladder,” Ghatalia, associate professor, Department of Hematology/Oncology, at Fox Chase Cancer Center in ...

Q: I am a woman in my early 70s who has been diagnosed with a bladder prolapse. I have no symptoms and was told I don’t need surgery until symptoms appear. I have since learned that this condition is ...